Chuaqui R, Vargas M P, Castiglioni T, Elsner B, Zhuang Z, Emmert-Buck M, Merino M J
Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892, USA.
Acta Cytol. 1996 Jul-Aug;40(4):642-8. doi: 10.1159/000333932.
To use the polymerase chain reaction (PCR) to detect loss of heterozygosity (LOH) in microdissected cells form cytologic smears obtained by fine needle aspiration (FNA) from 20 cases of invasive breast carcinoma.
In each case, histologic sections of the primary tumor were also available. Tumor and nontumor cells were dissected from both the cytologic smear and tissue section in all cases except in three smears that showed only tumor cells.
LOH was identified in 10 of 19 informative cases using two polymorphic DNA markers at chromosome 11q13 (INT-2, PYGM). The same results were obtained in both the cytologic and histologic specimens, including three cases that had hypocellular cytologic smears.
FNA of breast lesions provides adequate samples for direct microdissection of the cytologic smear to detect LOH using PCR amplification.
运用聚合酶链反应(PCR)检测通过细针穿刺抽吸(FNA)获取的20例浸润性乳腺癌细胞涂片经显微切割后的杂合性缺失(LOH)情况。
每例均有原发性肿瘤的组织学切片。除3例仅显示肿瘤细胞的涂片外,在所有病例中均从细胞涂片和组织切片中分离肿瘤细胞和非肿瘤细胞。
在19例信息充分的病例中,使用位于11q13染色体上的两个多态性DNA标记(INT-2、PYGM),在10例中鉴定出LOH。在细胞和组织标本中均获得相同结果,包括3例细胞涂片细胞数量少的病例。
乳腺病变的FNA可为直接对细胞涂片进行显微切割以利用PCR扩增检测LOH提供足够的样本。